Print Page  Close Window

SEC Filings

8-K
VITAE PHARMACEUTICALS, INC filed this Form 8-K on 10/25/2016
Entire Document
 

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.

 

 

 

 

 

2.1

 

Agreement and Plan of Merger by and between Allergan Holdco US, Inc., Augusta Merger Sub, Inc. and Vitae Pharmaceuticals, Inc., dated September 13, 2016 (incorporated by reference to Exhibit 2.1 to Vitae’s Current Report on Form 8-K filed with the SEC on September 14, 2016).

3.1

 

Amended and Restated Certificate of Incorporation of Vitae Pharmaceuticals, Inc., dated as of October 25, 2016.

3.2

 

Amended and Restated Bylaws of Vitae Pharmaceuticals, Inc., dated as of October 25, 2016.

 

4